Chemistry Nobel Honors Reactions That Choose One Molecular Hand

The 2026 Nobel Prize in Chemistry has gone to Henri B. Kagan and Kenso Soai for discoveries that taught chemical reactions to favour one of two mirror-image versions of a molecule. The Royal Swedish Academy of Sciences announced the award on 7 October, citing non-linear effects and autocatalysis in asymmetric organic synthesis.

Key fact: Soai's autocatalytic reaction could amplify a tiny initial imbalance until almost only one molecular mirror image remained.

Why molecules can have two hands

A chiral molecule can exist in two forms that contain the same atoms and bonds but cannot be placed exactly on top of each other, like left and right hands. These forms are called enantiomers. Living systems are themselves chiral, so enzymes and receptors may respond differently to each version.

That distinction matters in pharmaceuticals, fragrances and materials. Chemists therefore need reactions that reliably make the intended form. The challenge is related to the broader work of editing molecular structures without rebuilding them: both aim to give researchers finer control over which candidate they actually produce.

Kagan found a chemical amplifier

In 1986, Kagan showed that the relationship between a catalyst's handedness and the product could be strongly non-linear. A catalyst with only a modest excess of one mirror form could generate a much larger excess in the product. That finding overturned the simple expectation that selectivity must rise in direct proportion to catalyst purity.

Soai made the product copy its preference

Soai then developed asymmetric autocatalysis, a reaction in which the chiral product helps catalyse the creation of more product with the same handedness. His work, first reported in 1995 and pushed to near-complete selectivity by 2003, showed how a very small imbalance can reinforce itself through repeated cycles.

This provided an experimentally testable route by which homochirality, the dominance of one handedness, can emerge. It also gave asymmetric synthesis a striking demonstration of chemical amplification.

Why drug makers care

Manufacturing one enantiomer can improve efficacy, reduce unwanted effects and simplify purification when biological targets distinguish between mirror forms. The laureates' discoveries helped chemists understand catalysts and design selective reactions, although no single technique from the prize is responsible for every modern medicine.

What comes next

Kagan and Soai will share 12 million Swedish kronor. Their award follows this week's Physics Nobel for neutrino astronomy and places molecular selectivity at the centre of the chemistry prize. Future work will keep extending asymmetric catalysis while testing how small imbalances may have been amplified before biology began.